Socioeconomic and demographic characteristics influencing the hesitancy and refusal of COVID-19 vaccine in Ghana

Author:

Sampene Agyemang Kwasi1ORCID,Li Cai2,Oteng Agyeman Fredrick1,Brenya Robert3

Affiliation:

1. School of Management, Jiangsu University, Zhenjiang, China

2. School of Management, Jiangsu University, Zhenjiang 212013, Jiangsu, China

3. College of Economics and Management, Nanjing Agricultural University, Nanjing, China

Abstract

Background: Ghana was the first country to receive the coronavirus vaccination in West Africa from AstraZeneca or Oxford. Ghana plans to vaccinate 20 million out of the 32 million population and provide the necessary doses utilizing multilateral and bilateral agreements. As Ghana begins vaccinating its citizens, there is some skepticism about administering the coronavirus vaccine (CVV). This research aimed to analyze the socioeconomic and demographic characteristics influencing vaccine hesitancy (VH) and refusal among Ghanaians. Methods: The multinomial logistics regression model was employed to investigate the relationship between respondents’ socio-demographic characteristics and VH. The research data were gathered between March to June 2021 through an online survey. Findings: The findings of this study indicated that approximately 92.75% of the 400 respondents have heard about CVV. The study suggests that less than 5% of the participants have so far received the CVV. Most of the respondents (36.8%) indicated rejecting the CVV. Interestingly, male participants [adjusted odds ratio (AOR) = 1.048; 95% confidence interval (CI): 0.532–2.063] with higher educational backgrounds (AOR = 2.11; 95% CI: 0.870–5.121) had higher odds of being CVV hesitant or refusers. Low economic class, rural settlers, unmarried individuals, and unemployed people also had higher odds of being VH or refusers. The survey also shows that most Ghanaians refused to receive the CVV because they did not trust the system to track the vaccine’s side or adverse effects. Conclusion: Government can use social media platforms and other media platforms to effectively provide relevant information regarding the full benefit and risks of taking the virus.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Drug Discovery,Oncology,Immunology,Immunology and Allergy

Reference44 articles.

1. What policy makers need to know about COVID-19 protective immunity

2. World Health Organization. Ghana becomes recipient of historic first shipment of COVAX vaccines. WHO Regional Office for Africa, 2021, https://www.afro.who.int/news/ghana-becomes-recipient-historic-first-shipment-covax-vaccines (accessed 7 April 2021).

3. Gavi, the Vaccine Alliance. COVAX explained, 2021, https://www.gavi.org/vaccineswork/covax-explained (accessed 7 April 2021).

4. World Health Organization. Report of the SAGE working group on vaccine hesitancy, 2014, p. 64, https://www.asset-scienceinsociety.eu/sites/default/files/sage_working_group_revised_report_vaccine_hesitancy.pdf

5. COVID-19 vaccine hesitancy – reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3